These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 8174947)
1. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis. Pouderoux P; Kahrilas PJ Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654 [TBL] [Abstract][Full Text] [Related]
3. Cisapride in the treatment of gastro-oesophageal reflux disease. Robertson CS; Evans DF; Ledingham SJ; Atkinson M Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271 [TBL] [Abstract][Full Text] [Related]
4. The effect of cisapride in patients with reflux esophagitis: an ambulatory esophageal manometry/pH-metry study. Paterson WG; Wang H; Beck IT Am J Gastroenterol; 1997 Feb; 92(2):226-30. PubMed ID: 9040196 [TBL] [Abstract][Full Text] [Related]
5. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. McKenna CJ; Mills JG; Goodwin C; Wood JR Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711 [TBL] [Abstract][Full Text] [Related]
6. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children. Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928 [TBL] [Abstract][Full Text] [Related]
8. Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570 [TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial. McDougall NI; Watson RG; Collins JS; McFarland RJ; Love AH Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071 [TBL] [Abstract][Full Text] [Related]
10. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Ruth M; Finizia C; Cange L; Lundell L Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621 [TBL] [Abstract][Full Text] [Related]
11. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study. Pehlivanov N; Sarosiek I; Whitman R; Olyaee M; McCallum R Aliment Pharmacol Ther; 2002 Apr; 16(4):743-7. PubMed ID: 11929392 [TBL] [Abstract][Full Text] [Related]
12. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. Collins BJ; Spence RA; Ferguson R; Laird J; Love AH Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606 [TBL] [Abstract][Full Text] [Related]
13. Oesophageal function before, during, and after healing of erosive oesophagitis. Baldi F; Ferrarini F; Longanesi A; Angeloni M; Ragazzini M; Miglioli M; Barbara L Gut; 1988 Feb; 29(2):157-60. PubMed ID: 3345925 [TBL] [Abstract][Full Text] [Related]
14. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial. Arvanitakis C; Nikopoułos A; Theoharidis A; Giannoulis E; Vagios I; Anthopoulou H; Michailidis D; Tourkantonis A Aliment Pharmacol Ther; 1993 Dec; 7(6):635-41. PubMed ID: 8161670 [TBL] [Abstract][Full Text] [Related]
15. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice. Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973 [TBL] [Abstract][Full Text] [Related]
16. A comparison of five maintenance therapies for reflux esophagitis. Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948 [TBL] [Abstract][Full Text] [Related]
17. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. Finizia C; Lundell L; Cange L; Ruth M Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):9-14. PubMed ID: 11782569 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Hatlebakk JG; Berstad A Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586 [TBL] [Abstract][Full Text] [Related]